Agilon Health, Inc. (NYSE:AGL – Get Free Report) shares fell 5.1% on Tuesday . The stock traded as low as $81.95 and last traded at $81.97. 107,183 shares were traded during trading, a decline of 71% from the average session volume of 365,729 shares. The stock had previously closed at $86.39.
Analysts Set New Price Targets
Several research firms recently weighed in on AGL. Wall Street Zen upgraded shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a research note on Monday, May 4th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $72.00 target price (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. Finally, Robert W. Baird upped their target price on Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $58.73.
Read Our Latest Report on Agilon Health
Agilon Health Price Performance
Agilon Health (NYSE:AGL – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. As a group, research analysts predict that Agilon Health, Inc. will post -3.75 EPS for the current year.
Hedge Funds Weigh In On Agilon Health
Institutional investors and hedge funds have recently modified their holdings of the stock. CenterBook Partners LP increased its holdings in Agilon Health by 492.4% in the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after buying an additional 9,499,012 shares in the last quarter. Atwater Malick LLC increased its holdings in Agilon Health by 100.0% in the 4th quarter. Atwater Malick LLC now owns 197,576 shares of the company’s stock worth $136,000 after buying an additional 98,788 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Agilon Health by 209.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,105,297 shares of the company’s stock worth $2,168,000 after buying an additional 1,425,052 shares in the last quarter. Pallas Capital Advisors LLC bought a new stake in Agilon Health in the 4th quarter worth about $59,000. Finally, Quantbot Technologies LP bought a new stake in Agilon Health in the 3rd quarter worth about $381,000.
Agilon Health Company Profile
Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.
Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.
Featured Articles
- Five stocks we like better than Agilon Health
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
